Type 1 Diabetes

Join Clinical Trials Type 1 Diabetes

Diabetes (Type 1) Clinical Trials

General purpose: Research related to type 1 diabetes may investigate new methods for diagnosing diabetes, ways to refine the diagnostic accuracy of existing test methods, improved treatment options (such as different insulin delivery methods or newly developed oral medications designed to control blood glucose levels), and behavioral / lifestyle factors that can aid in the management of type 1 diabetes.

In addition, research may also look at possible genetic factors that might make a person more likely to develop type 1 diabetes.

Diabetes Type 1 Clinical Trials Continued … (Click to Open)

Diabetes (Type 1) Clinical Trials

Type 1 Diabetes Clinical Trials

What do typical clinical trials for Type 1 Diabetes involve?

Clinical trials will vary widely in the information they collect, as well as the tests and procedures they use. All of these factors will depend on individual study designs, which will differ greatly between trials.

However, below is a list of common procedures and data that are frequently collected during a trial for Type 1 Diabetes:

  • Fasting blood glucose levels.
  • Random blood glucose levels.
  • Oral glucose tolerance tests, which involves drinking a sweet drink with a known amount of glucose and then having blood drawn at regular intervals over a specified period of time (usually several hours).
  • Hemoglobin A1c test, which measures an individual’s average blood glucose level over a two to three month period.
  • Urine sample or blood sample to measure ketone levels (ketones are produced when the body burns fat for energy rather than glucose).
  • Monitoring of body weight.
  • Monitoring of cholesterol and triglyceride levels, blood pressure, kidney function, and nerve function.
  • Visual inspection of the skin and bones on feet and legs.
  • Food intake monitoring using food diaries or computer-based tracking systems.

Examples of Type 1 Diabetes-related research topics:

  • Immune therapy for the prevention and treatment of diabetes.
  • New therapies designed to improve glucose control.
  • New therapies designed to treat the complications associated with diabetes, such as nerve pain, vision loss, and kidney damage.
  • Research designed to develop vaccines against the factors that trigger the immune system to attack the pancreas.
  • Development of new therapies to stop or reverse the immune system’s attack on the pancreas, thereby removing the need for insulin therapy.

Suggested search terms for best results:  “obesity and diabetes,” “children and diabetes,” “insulin and diabetes,” “diabetes prevention,” “diabetes treatment.”


Access denied for user ''@'localhost' (using password: NO)